PRZ-AMLODIPINE is a brand name for Amlodipine, supplied as a tablet. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: PRZ-AMLODIPINE (amlodipine besylate tablets) is indicated for: • Hypertension PRZ-AMLODIPINE is indicated in the treatment of mild to moderate essential hypertension. Combination of amlodipine besylate with a diuretic, a beta-blocking agent, or an angiotensin converting enzyme inhibitor has been found to be compatible…
Verbatim from this product's HC label. Tap a section to expand.
1 Dosing Considerations Dosage should be individualized depending on patient's tolerance and responsiveness. 2 Recommended Dose and Dosage Adjustment • For both hypertension and angina, the recommended initial dose of PRZ-AMLODIPINE is 5 mg once daily.
If necessary, dose can be increased after 1-2 weeks to a maximum dose of 10 mg once daily. • Use in the Elderly or in Patients with Impaired Renal Function: The recommended initial dose in patients over 65 years of age or patients with impaired renal function is 5 mg once daily.
4 Geriatrics). • Use in Patients with Impaired Hepatic Function: Dosage requirements have not been established in patients with impaired hepatic function. When PRZ-AMLODIPINE is used in these patients, the dosage should be carefully and gradually adjusted depending on patients tolerance and response.
5 mg once daily should be considered (see 7 WARNINGS AND PRECAUTIONS, Hepatic/Biliary/Pancreatic). 5 mg to 5 mg once daily. 2 Pharmacodynamics). 4 Administration PRZ-AMLODIPINE can be administered once daily, at any time of the day, with or without food.
5 Missed Dose The patient should be advised that if they miss a dose, it should be taken immediately unless it has been more than 12 hours since the missed dose. In such an event, the patient should wait for the next scheduled dose and continue on the regular schedule.
A double dose should not be taken to make up for a missed dose.
, Hepatic/Biliary/Pancreatic). 5 mg to 5 mg once daily. 2 Pharmacodynamics). 4 Administration PRZ-AMLODIPINE can be administered once daily, at any time of the day, with or without food. 5 Missed Dose The patient should be advised that if they miss a dose, it should be taken immediately unless it has been more than 12 hours since the missed dose.
In such an event, the patient should wait for the next scheduled dose and continue on the regular schedule. A double dose should not be taken to make up for a missed dose. 5 OVERDOSAGE Symptoms: Overdosage can cause excessive peripheral vasodilation with marked and probably prolonged hypotension and possibly a reflex tachycardia.
In humans, experience with overdosage of amlodipine besylate tablets are limited. In healthy volunteers, the use of charcoal up to 2 hours after administration of amlodipine 10 mg has been shown to reduce the absorption rate of amlodipine.
A patient who took 70 mg of amlodipine with benzodiazepine developed shock which was refractory to treatment and died. In a 19 month old child who ingested 30 mg of amlodipine (about 2 mg/kg) there was no evidence of hypotension but tachycardia (180 bpm) was observed.
5 hrs after ingestion and on subsequent observation (overnight) no sequelae were noted.
Treatment:
Clinically significant hypotension due to overdosage requires active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output.
A vasoconstrictor (such as norepinephrine) may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. As amlodipine besylate tablets are highly protein bound, hemodialysis is not likely to be of benefit.
PRZ-AMLODIPINE is contraindicated in patients:
PRZ-AMLODIPINE (amlodipine besylate) Page 5 of 37 • who are hypersensitive to this drug or to any ingredient in the formulation, including any non – medicinal ingredient, or component of the container. For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING.
• who are hypersensitive to other dihydropyridines. Amlodipine besylate is a dihydropyridine calcium channel blocker. 2 Breast-feeding). g. high grade aortic stenosis) • with haemodynamically unstable heart failure after acute myocardial infarction
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Amlodipine in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Clearance of amlodipine is prolonged in elderly patients and in patients with impaired liver function. For management of a suspected drug overdose, contact your regional poison control centre.
6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING Table 1. 5 mg, 5 mg, 10 mg Calcium hydrogen phosphate anhydrous, magnesium stearate, microcrystalline cellulose, and sodium starch glycolate. 5 mg, 5 mg and 10 mg amlodipine per tablet.
5” on other side. They are available in bottles of 100s. PRZ-AMLODIPINE 5 mg tablets are white to off-white coloured, elongated octagon shaped, flat faced beveled edged tablets debossed with “5” on one side and “PRZ” on other side. They are available in bottles of 100s and 500s.
PRZ-AMLODIPINE 10 mg tablets are white to off-white coloured, elongated octagon shaped, flat faced beveled edged, tablets debossed with “10” on one side and “PRZ” on other side. They are available in bottles of 500s. 7 WARNINGS AND PRECAUTIONS General Beta-blocker withdrawal: PRZ-AMLODIPINE gives no protection against the dangers of abrupt beta-blocker withdrawal and such withdrawal should be done by the gradual reduction of the dose of beta-blocker.
4 Drug-Drug Interactions). Such concomitant use should be avoided. I. 02)].
Cardiovascular Increased Angina and/or Myocardial Infarction:
Rarely, patients, particularly those with severe obstructive coronary artery disease, have developed documented increased frequency, duration and/or severity of angina or acute myocardial infarction on starting calcium channel blocker therapy or at the time of dosage increase.
The mechanism of this effect has not been elucidated. PRZ-AMLODIPINE (amlodipine besylate) Page 8 of 37 Use in Patients with Congestive Heart Failure: Although calcium channel blockers should only be used with caution in patients with heart failure, it has been observed that amlodipine besylate tablets had no overall deleterious effect on survival and cardiovascular morbidity in both short-term and long-term clinical trials in these patients.
While a significant proportion of the patients in these studies had a history of ischemic heart disease, angina or hypertension, the studies were not designed to evaluate the treatment of angina or hypertension in patients with concomitant heart failure.
Of note, in an amlodipine long-term, placebo-controlled study in patients with severe heart failure (NYHA class III and IV), the reported incidence of pulmonary edema was higher in the amlodipine treated group than in the placebo group.
Calcium channel blockers, including amlodipine, may increase the risk of future cardiovascular events and mortality.
Hypotension:
PRZ-AMLODIPINE may occasionally precipitate symptomatic hypotension. Careful […]
+1 more